medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Number 6

<< Back Next >>

Ann Hepatol 2014; 13 (6)

Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico

López-Colombo A, Meléndez-Mena D, Sedeño-Monge V, Camacho-Hernández JR, Vázquez-Cruz E, Morales-Hernández ER, Sosa-Jurado F, Márquez-Domínguez L, Santos-López G

Language: English
References: 26
Page: 746-752
PDF size: 97.66 Kb.


ABSTRACT

Background. Approximately 180 million persons (~2.8%) globally are estimated to be infected by hepatitis C virus (HCV). HCV prevalence in Mexico has been estimated to be between 1.2 and 1.4%. The aim of present work was to determine the prevalence of HCV infection in patients and family members attending two primary care clinics in Puebla, Mexico. Material and methods. Patients and their accompanying family members in two clinics were invited to participate in this study between May and September 2010. Results. A total of 10,214 persons were included in the study; 120 (1.17%) persons were anti-HCV reactive. Of the reactive subjects, detection of viral RNA was determined in 114 subjects and 36 were positive (31%). The more frequent risk factors were having a family history of cirrhosis (33.1%) and having a blood transfusion prior to 1995 (29%). After a multiple logistic regression analysis only transfusion prior to 1995 resulted significant to HCV transmission (p = 0.004). The overall detected HCV genotypes were as follows: 1a (29%), 1b (48.5%), 2/2b (12.8%), and 3a (6.5%). Conclusion. The HCV prevalence in this population is in agreement with previous studies in other regions of Mexico.


REFERENCES

  1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-42.

  2. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 47-52.

  3. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection 2011; 17: 107-15.

  4. Chevaliez S, Pawlotsky JM. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006; 3: 35-40.

  5. Sosa-Jurado F, Santos-Lopez G, Guzman-Flores B, Ruiz-Conde JI, Melendez-Mena D, Vargas-Maldonado MT, Martinez- Laguna Y, et al. Hepatitis C virus infection in blood donors from the state of Puebla, Mexico. Virol J 2010; 7: 18.

  6. Alvarado-Mora MV, Pinho JR. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther 2013; 18: 429-33.

  7. Fundación Mexicana para la Salud Hepática. La hepatitis C como un problema de salud pública en México. Sal Pub Mex 2011; 53: S61-S67.

  8. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, Palma O, Kershenobich D, Sepúlveda J. Seroprevalencia de la hepatitis C en adultos de México: ¿ un problema de salud pública emergente. Sal Pub Mex 2007; 49: s395-s403.

  9. Santos-Lopez G, Sosa-Jurado F, Vallejo-Ruiz V, Melendez- Mena D, Reyes-Leyva J. Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infection 2008; 56: 281-90.

  10. Chiquete E, Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review. Intervirology 2007; 50: 1-8.

  11. Anonimous. Morbilidad y mortalidad por cirrosis hepática. In: Salud: México 2006. México, D.F.: Secretaría Salud; 2007.

  12. Anonimous. Programa Nacional de Salud 2007-2012. México, D.F., México: Secretaría de Salud; 2007.

  13. Burguete-García AI, Conde-González CJ, Jimenez-Mendez R, Juarez-Diaz Y, Meda-Monzon E, Torres-Poveda K, Madrid- Marina V. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico. Sal Pub Mex 2011; 53(Suppl. 1): S7-S12.

  14. Romero-Figueroa S, Ceballos-Salgado E, Santillan-Arreygue L, Miranda-Garcia M, Rubio-Lezama M, Garduno-Garcia JJ. Risk factors associated with hepatitis C virus infection in an urban population of the State of Mexico. Archives of Virology 2012; 157: 329-32.

  15. Campollo O, Roman S, Panduro A, Hernandez G, Diaz-Barriga L, Balanzario MC, Cunningham JK. Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend 2012; 123: 269-72.

  16. Mendez-Sanchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M. Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary- care hospital in Mexico City, Mexico. J Clin Microbiol 2004; 42: 4321-2.

  17. White EF, Garfein RS, Brouwer KC, Lozada R, Ramos R, Firestone-Cruz M, Perez SG, et al. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Sal Pub Mex 2007; 49: 165-72.

  18. Dehesa-Violante M, Bosques-Padilla F, Kershenobich-Stalnikowitz D. Prevalence of hepatitis C virus genotypes in Mexican patients. Rev Gastroenterol Mex 2007; 72: 344-8. López-Colombo A, et al. , 2014; 13 (6): 746-752 752

  19. Garcia-Montalvo BM, Macossay-Castillo M. Preliminary data for genotype distribution and epidemiological aspects of hepatitis C virus infection in blood donors from Yucatan, Mexico. Transfusion Medicine 2007; 17: 488-90.

  20. Rivas-Estilla AM, Cordero-Perez P, Trujillo-Murillo Kdel C, Ramos-Jimenez J, Chen-Lopez C, Garza-Rodriguez Mde L, Ramirez-Gutierrez A, et al. Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico. Ann Hepatol 2008; 7: 144-7.

  21. Idrovo AJ, Fernandez JA. Which is the real genotype distribution of hepatitis C virus infection in Mexico? Ann Hepatol 2008; 7: 389.

  22. Garcia-Montalvo BM, Galguera-Colorado PL. Distribution of hepatitis C virus genotypes, risk factors and liver disease in patients from Yucatan, Mexico. Ann Hepatol 2008; 7: 345-9.

  23. Mendez-Sanchez N, Gutierrez-Grobe Y, Kobashi-Margain RA. Epidemiology of HCV infection in Latin America. Ann Hepatol 2010; 9(Suppl.): 27-9.

  24. Jimenez-Mendez R, Uribe-Salas F, Lopez-Guillen P, Cisneros- Garza L, Castaneda-Hernandez G. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico. Ann Hepatol 2010; 9: 33-9.

  25. Dehesa-Violante M, Nunez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res 2007; 38: 606-11.

  26. Oliveira-Filho AB, Pimenta Ado S, Rojas Mde F, Chagas MC, Crespo DM, Crescente JA, Lemos JA. Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Para, Northern Brazil. Cad Saude Publica 2010; 26: 837-44.




2020     |     www.medigraphic.com